Long noncoding RNA uc173 is a novel regulator of mitochondrial metabolism driving intestinal mucosal growth.

IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Lan Xiao, Song Ah Chae, Dongyoon Yoo, Hee K Chung, Min S Kwon, Amy VanderStoep, Ting-Xi Yu, Bridgette Warner, Myriam Gorospe, Jian-Ying Wang
{"title":"Long noncoding RNA uc173 is a novel regulator of mitochondrial metabolism driving intestinal mucosal growth.","authors":"Lan Xiao, Song Ah Chae, Dongyoon Yoo, Hee K Chung, Min S Kwon, Amy VanderStoep, Ting-Xi Yu, Bridgette Warner, Myriam Gorospe, Jian-Ying Wang","doi":"10.1016/j.jcmgh.2025.101653","DOIUrl":null,"url":null,"abstract":"<p><strong>Background & aims: </strong>Long noncoding RNA uc.173, transcribed from ultraconserved regions, modulates many cell processes central to human pathologies, but the mechanism underlying uc.173 in the homeostasis of the intestinal epithelium is underexplored. Here we investigated the role of uc.173 in regulating mitochondrial metabolism and defined the implication of altered mitochondrial activity by uc.173 in renewal of the intestinal mucosa.</p><p><strong>Methods: </strong>Studies were conducted in CRISPR-Cas9 knock-in mice, primary enterocytes, and Caco-2 cells. Mitochondrial structure and function were elucidated by measuring mitochondria-associated proteins and mitochondrial respiratory capacity. Intestinal mucosal growth was measured by Ki67 immunostaining or BrdU incorporation assays.</p><p><strong>Results: </strong>Transient and specific deletion of uc.173 in the intestinal epithelium of mice by CRISPR-Cas9 knock-in using small guide RNA decreased the levels of several mitochondria-associated proteins including PGC-1α, along with disrupted mucosal growth. Decreasing the levels of uc.173 in cultured intestinal epithelial cells also decreased mitochondrial proteins and caused defects in the mitochondrial respiratory capacity. Reinforcing mitochondrial activity by using a mitochondrial activator or by overexpressing PGC-1α rescued growth of uc.173-deficient intestinal organoids. Mechanistic studies revealed that uc.173 increased PGC-1α expression by acting as a molecular decoy for miR-29b, thereby preventing the repressive interaction of miR-29b with PGC-1α mRNA.</p><p><strong>Conclusions: </strong>These findings indicate that uc.173 is a novel regulator of mitochondrial metabolism in the intestinal epithelium and highlight a role of deregulation of uc.173, miR-29b, and PGC-1α in the suppressed renewal of intestinal mucosa in patients with critical illnesses.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101653"},"PeriodicalIF":7.1000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and Molecular Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jcmgh.2025.101653","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background & aims: Long noncoding RNA uc.173, transcribed from ultraconserved regions, modulates many cell processes central to human pathologies, but the mechanism underlying uc.173 in the homeostasis of the intestinal epithelium is underexplored. Here we investigated the role of uc.173 in regulating mitochondrial metabolism and defined the implication of altered mitochondrial activity by uc.173 in renewal of the intestinal mucosa.

Methods: Studies were conducted in CRISPR-Cas9 knock-in mice, primary enterocytes, and Caco-2 cells. Mitochondrial structure and function were elucidated by measuring mitochondria-associated proteins and mitochondrial respiratory capacity. Intestinal mucosal growth was measured by Ki67 immunostaining or BrdU incorporation assays.

Results: Transient and specific deletion of uc.173 in the intestinal epithelium of mice by CRISPR-Cas9 knock-in using small guide RNA decreased the levels of several mitochondria-associated proteins including PGC-1α, along with disrupted mucosal growth. Decreasing the levels of uc.173 in cultured intestinal epithelial cells also decreased mitochondrial proteins and caused defects in the mitochondrial respiratory capacity. Reinforcing mitochondrial activity by using a mitochondrial activator or by overexpressing PGC-1α rescued growth of uc.173-deficient intestinal organoids. Mechanistic studies revealed that uc.173 increased PGC-1α expression by acting as a molecular decoy for miR-29b, thereby preventing the repressive interaction of miR-29b with PGC-1α mRNA.

Conclusions: These findings indicate that uc.173 is a novel regulator of mitochondrial metabolism in the intestinal epithelium and highlight a role of deregulation of uc.173, miR-29b, and PGC-1α in the suppressed renewal of intestinal mucosa in patients with critical illnesses.

长链非编码RNA uc173是一种新的线粒体代谢调节因子,驱动肠粘膜生长。
背景与目的:长链非编码RNA。173从超保守区域转录,调节许多对人类病理至关重要的细胞过程,但uc的潜在机制。173在肠上皮内稳态中的作用尚不清楚。在这里,我们研究了uc的作用。173在调节线粒体代谢中的作用,并定义了uc改变线粒体活性的意义。173在肠粘膜的更新。方法:在CRISPR-Cas9敲入小鼠、原代肠细胞和Caco-2细胞中进行研究。通过测定线粒体相关蛋白和线粒体呼吸能力来阐明线粒体结构和功能。采用Ki67免疫染色法或BrdU掺入法测定肠黏膜生长。结果:uc的瞬时特异性缺失。使用小向导RNA通过CRISPR-Cas9敲入小鼠肠上皮中的173,降低了包括PGC-1α在内的几种线粒体相关蛋白的水平,同时破坏了粘膜生长。降低uc的水平。173在培养的肠上皮细胞中也降低了线粒体蛋白,导致线粒体呼吸能力缺陷。通过使用线粒体激活剂或过表达PGC-1α来增强线粒体活性可挽救uc的生长。173缺乏肠道类器官。机理研究表明,uc。173通过作为miR-29b的分子诱饵增加PGC-1α的表达,从而阻止miR-29b与PGC-1α mRNA的抑制性相互作用。结论:这些发现提示uc。173是一种新的肠上皮线粒体代谢调节因子,并在uc的解除管制中发挥重要作用。173、miR-29b和PGC-1α在危重症患者肠黏膜更新抑制中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
13.00
自引率
2.80%
发文量
246
审稿时长
42 days
期刊介绍: "Cell and Molecular Gastroenterology and Hepatology (CMGH)" is a journal dedicated to advancing the understanding of digestive biology through impactful research that spans the spectrum of normal gastrointestinal, hepatic, and pancreatic functions, as well as their pathologies. The journal's mission is to publish high-quality, hypothesis-driven studies that offer mechanistic novelty and are methodologically robust, covering a wide range of themes in gastroenterology, hepatology, and pancreatology. CMGH reports on the latest scientific advances in cell biology, immunology, physiology, microbiology, genetics, and neurobiology related to gastrointestinal, hepatobiliary, and pancreatic health and disease. The research published in CMGH is designed to address significant questions in the field, utilizing a variety of experimental approaches, including in vitro models, patient-derived tissues or cells, and animal models. This multifaceted approach enables the journal to contribute to both fundamental discoveries and their translation into clinical applications, ultimately aiming to improve patient care and treatment outcomes in digestive health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信